Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Michael McGarrity, William Moffitt, William White, Mark Slezak, and Others

Premium

Nanosphere said this month in its fourth-quarter financial report that it has promoted Michael McGarrity to succeed William Moffitt as its new president and CEO.

McGarrity previously was vice president of sales and marketing and chief commercial officer at the Northbrook, Ill.-based firm. Moffitt had led Nanosphere as CEO and president since his appointment in 2004.

As part of the shakeup, Moffitt, William White, Mark Slezak, and Roy Davis all resigned from Nanosphere's board of directors. The company said it has appointed Sheli Rosenberg, Michael Ward, and McGarrity to replace them. Rosenberg, who served on Nanosphere's board from 2002 to 2012, will be its new chair.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.